SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-247281
Filing Date
2018-08-13
Accepted
2018-08-13 16:10:09
Documents
64
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d514761d10q.htm 10-Q 833025
2 EX-31.1 d514761dex311.htm EX-31.1 7025
3 EX-31.2 d514761dex312.htm EX-31.2 6955
4 EX-32.1 d514761dex321.htm EX-32.1 3684
5 EX-32.2 d514761dex322.htm EX-32.2 3716
  Complete submission text file 0001193125-18-247281.txt   3755316

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT umrx-20180630.xml EX-101.INS 594778
7 XBRL TAXONOMY EXTENSION SCHEMA umrx-20180630.xsd EX-101.SCH 40815
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE umrx-20180630_cal.xml EX-101.CAL 57410
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE umrx-20180630_def.xml EX-101.DEF 141098
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE umrx-20180630_lab.xml EX-101.LAB 343294
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE umrx-20180630_pre.xml EX-101.PRE 247615
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 181012350
SIC: 2834 Pharmaceutical Preparations